1. Managing Pulmonary Embolism Posthospital Discharge

3. Burden of VTE

4. Phases of VTE Treatment

5. NOAC Doses in Acute VTE Treatment Trials

6. Efficacy and Safety of NOACs: Meta-Analysis of Acute VTE Treatment Trials

7. EINSTEIN-PE: Treatment of Acute Symptomatic PE

8. Phase III Acute VTE Studies With NOACs: Subgroup With Index PE ± DVT

9. VTE Extension Trials: Efficacy and Safety Outcomes

10. EINSTEIN CHOICE: Study Design

11. EINSTEIN CHOICE: Primary Outcome -- Recurrent VTE

12. EINSTEIN CHOICE: Bleeding Outcomes

13. Extended Treatment: NNTB

14. Risk of VTE Recurrence: Based on Type of VTE Event

15. VTE Provoked by Surgery: Risk of Recurrence

16. VTE Provoked by Nonsurgical Transient Risk Factors: Risk of Recurrence

17. Unprovoked VTE: Risk of Recurrence

18. Benefit/Risk of Extended Treatment

19. Era of NOACs: Shift in Extended Anticoagulation

20. VTE Treatment Phases: Anticoagulant Dosing in the Era of NOACs

21. Approach to Improving Medication Adherence

22. INSPIRE: Aspirin for Prevention of Recurrent VTE

23. Extended VTE Treatment in the Era of NOACs

24. PE Home Treatment: 2016 CHEST Guidelines

25. Post-PE Care: Follow-Up in the First Year

26. Summary

27. Abbreviations

28. Abbreviations (cont)